Ultrasound evaluation of perihepatic lymph nodes during antiviral therapy with the protease inhibitor telaprevir (VX-950) in patients with chronic hepatitis C infection

被引：1
|
作者：
Friedrich-Rust, M.
Forestier, N.
Sarrazin, C.
Reesink, H. W.
Herrmann, E.
Zeuzem, S.
机构：
[1] Saarland Univ Hosp, Dept Internal Med, Saarland, Germany
[2] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)62137-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
539
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [1] Ultrasound evaluation of perihepatic lymph nodes during antiviral therapy with the protease inhibitor telaprevir (VX-950) in patients with chronic hepatitis c infection
    Friedrich-Rust, Mirfen
    Forestier, Nicole
    Sarrazin, Christoph
    Reesink, Henk W.
    Herrmann, Eva
    Zeuzem, Stefan
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2007, 33 (09): : 1362 - 1367
  • [2] Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C
    Forestier, Nicole
    Reesink, Hendrik W.
    Weegink, Christine J.
    McNair, Lindsay
    Kieffer, Tara L.
    Chu, Hui-May
    Purdy, Susan
    Jansen, Peter L. M.
    Zeuzem, Stefan
    [J]. HEPATOLOGY, 2007, 46 (03) : 640 - 648
  • [3] Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C infection
    Dietrich, CF
    Stryjek-Kaminska, D
    Teuber, G
    Lee, JH
    Caspary, WF
    Zeuzem, S
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (03) : 699 - 704
  • [4] Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C
    Dietrich, CF
    Stryjek-Kaminska, D
    Caspary, WF
    Zeuzem, S
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A1203 - A1203
  • [5] Tolerability and antiviral effects in a 28-day study of the hepatitis C protease inhibitor Telaprevir (VX-950), in combination with peg-interforon-alpha-2a and ribavirin
    Lawitz, E.
    Rodriguez-Torres, M.
    Muir, A.
    Keane, J.
    Kieffer, T.
    McNair, L.
    McHutchison, J.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S239 - S239
  • [6] Neopterin and alt as markers of inflammation in chronic hepatitis C patients during administration of the HCVNS3-4a protease inhibitor telaprevir (VX-950) in combination with peginterferon ALFA 2a
    Gelderblom, H. C.
    Zeuzem, S.
    Weegink, C. J.
    Forestier, N.
    McNair, L.
    Purdy, S.
    Jansen, P. L. M.
    Reesink, H. W.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S224 - S225
  • [7] Perihepatic lymph nodes in patients with chronic hepatitis G and C.
    Dietrich, CF
    Sarrazin, C
    Teuber, G
    Caspary, WF
    Zeuzem, S
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A1257 - A1257
  • [8] Genotype Differences in Susceptibility and Resistance Development of Hepatitis C Virus to Protease Inhibitors Telaprevir (VX-950) and Danoprevir (ITMN-191)
    Imhof, Ingrid
    Simmonds, Peter
    [J]. HEPATOLOGY, 2011, 53 (04) : 1090 - 1099
  • [9] Decline in serum neopterin concentration correlates with HCV RNA decline during administration of VX-950, a hepatitis C virus protease inhibitor
    Gelderblom, HC
    Zeuzem, S
    Weegink, CJ
    Forestier, N
    McNair, L
    Purdy, S
    Jansen, PL
    Reesink, HW
    [J]. HEPATOLOGY, 2005, 42 (04) : 533A - 534A
  • [10] VX-950, a novel hepatitis C virus (HCV) NS34A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells
    Lin, K
    Perni, RB
    Kwong, AD
    Lin, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1813 - 1822
12345